Mountain View, CA—The Takara Bio Group, the leading provider of human stem cell differentiation services globally, has launched the Cellartis Directed Differentiation to Beta Cells Service for the delivery of high-quality, custom human induced pluripotent stem cell (hiPSC)-derived beta cells for diabetes research and metabolic disease modeling. The gold standard in this field involves the use of […]
AstraZeneca is the first pharmaceutical company to work with Emulate to develop and embed its Organs-on-Chips technology in its laboratories Studies with the technology aim to gain new insights into disease mechanisms BOSTON, Mass. — Emulate, Inc. has formed a collaborative partnership with AstraZeneca’s Innovative Medicines and Early Development (IMED) Biotech Unit to embed its Organs-on-Chips technology within […]
MR Solutions is broadening its range of preclinical scanners with the launch of four CT models. This new range of CT scanners is designed to operate alone or with the clip on PET and SPECT imaging systems developed by MR Solutions for their range of MRI scanners. The MR Solutions family now includes six cryogen […]
TTP Plc (TTP), a leading independent technology and product development company, and Camena Bioscience, a developer of pioneering technology that profiles small molecules, such as metabolites, nutrients or medicines in liquid samples, announced today that they are collaborating to develop an instrument to monitor the health of cell cultures. The new instrument will be used […]
SUNNYVALE, CA ClearLight Diagnostics, LLC (ClearLight), an early stage developer of an automated, next generation tissue processing and 3D imaging/image analysis platform, announced today that Laurie Goodman, PhD, Chief Scientific Officer, has assumed the position of Interim Chief Executive Officer and has been selected as a Board Member. Dr. Goodman will continue in her role as […]
Reinforcing Our Diagnostic Reagent Development and Production Function by Establishing a Location to Handle Integrated Development through Production and Distribution of Bio-Diagnostic Reagents Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announces plans to establish the Bio-Diagnostic Reagent Center to boost the Company’s competitiveness and provide a stable supply of “diagnostic reagents using […]
ST. LOUIS and ROYSTON, HERTS — Dolomite Bio, a leading provider of high throughput single cell technology, and Partek Incorporated, a recognized leader in the development of powerful genomic data analysis tools – today announced a collaboration to combine Partek’s single cell data analysis capabilities with Dolomite Bio’s microfluidic droplet-based single cell technology. Single cell data […]
Greiner Bio-One Magnetic 3D Cell Culture Products Greiner Bio-One North America, Inc. has acquired 3D Cell Culture Technology previously owned by Nano 3D Biosciences, Inc. As an international distributor of these products since 2016, Greiner Bio-One has now taken the initiative to become a premier provider of this technology worldwide. Magnetic 3D cell culture has […]
Genome BC Invests $1 million in Funding to Top Canadian 3D Bioprinting Company Aspect Biosystems Vancouver, Canada — Genome BC is pleased to announce $1 million in funding to Aspect Biosystems (Aspect), a privately held biotechnology company focused on commercializing cutting-edge 3D bioprinting technologies. Aspect’s Lab-on-a-Printer™ 3D bioprinting platform technology enables the rapid creation of functional […]
A new partnership between Leica Microsystems and Bar-Ilan University, Ramat-Gan, Israel is officially in place Wetzlar, Germany. Leica Microsystems are pleased to announce a new collaboration with the Bar-Ilan University, Ramat-Gan, Israel. The new agreement aims to promote and establish Bar-Ilan as a new reference site for Leica products and workflows. As part of the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
